Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update describes testing serplulimab with induction chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma, with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serplulimab (serplulimab)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Locally Advanced Nasopharyngeal Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING